Inflammatory polyneuropathy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Critical patients; submitted to mechanical ventilation; no signs of hypertension or hypotension; normal electrocardiogram; show no signs of respiratory distress; clinical-laboratory tests within normal values.
Exclusion criteria
Exclusion criteria: Patient with signs of intracranial hypertension; inability to walk without assistance before acute illness in the ICU; pregnant women; obese; use of cardiac pacemaker; diagnoses of neurological, vascular, orthopedic and oncological pathologies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of inflammatory cytokine values by at least 5% of the baseline values, measured by laboratory tests before and one hour after the intervention;Reduction of monocyte-mediated cellular nitric oxide values by at least 10% of baseline values, measured by laboratory tests before and one hour after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil
Contacts
Hospital Agamenon Magalhães